BELLEI, Monica
 Distribuzione geografica
Continente #
NA - Nord America 8.278
AS - Asia 2.973
EU - Europa 2.821
SA - Sud America 401
AF - Africa 128
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.652
Nazione #
US - Stati Uniti d'America 8.132
GB - Regno Unito 920
SG - Singapore 715
CN - Cina 712
HK - Hong Kong 371
VN - Vietnam 360
IT - Italia 327
DE - Germania 313
SE - Svezia 305
BR - Brasile 293
FI - Finlandia 171
FR - Francia 157
RU - Federazione Russa 149
TR - Turchia 149
UA - Ucraina 144
BD - Bangladesh 141
IN - India 89
JP - Giappone 89
CA - Canada 79
KR - Corea 68
BG - Bulgaria 61
BE - Belgio 49
IE - Irlanda 43
AU - Australia 42
ID - Indonesia 38
IQ - Iraq 37
AR - Argentina 36
ZA - Sudafrica 36
MX - Messico 35
NL - Olanda 31
EG - Egitto 27
IL - Israele 24
MY - Malesia 23
TN - Tunisia 22
IR - Iran 21
PK - Pakistan 21
AE - Emirati Arabi Uniti 20
EC - Ecuador 19
MA - Marocco 19
CL - Cile 18
ES - Italia 18
PL - Polonia 17
TW - Taiwan 16
CH - Svizzera 13
CO - Colombia 13
PT - Portogallo 12
SA - Arabia Saudita 12
RO - Romania 11
AT - Austria 10
BZ - Belize 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
NO - Norvegia 9
UZ - Uzbekistan 9
DK - Danimarca 8
EE - Estonia 8
LT - Lituania 8
PH - Filippine 8
LB - Libano 7
RS - Serbia 7
UY - Uruguay 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KE - Kenya 6
NZ - Nuova Zelanda 6
PA - Panama 5
VE - Venezuela 5
HU - Ungheria 4
PE - Perù 4
TH - Thailandia 4
AM - Armenia 3
BO - Bolivia 3
GR - Grecia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MK - Macedonia 3
NP - Nepal 3
PY - Paraguay 3
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
Totale 14.637
Città #
Ashburn 1.142
Fairfield 797
Santa Clara 638
Southend 591
Woodbridge 498
Singapore 451
Chandler 380
Houston 361
Hong Kong 325
Jacksonville 271
Seattle 271
Wilmington 270
Cambridge 240
Ann Arbor 214
Dearborn 202
San Jose 198
Hefei 180
Nyköping 177
Dallas 174
Beijing 151
Los Angeles 149
London 134
Chicago 120
Council Bluffs 116
Helsinki 116
New York 104
Ho Chi Minh City 103
Frankfurt am Main 86
Hanoi 78
The Dalles 77
Redwood City 65
Izmir 63
Sofia 59
Modena 58
San Diego 58
Princeton 55
Seoul 51
Eugene 50
Bremen 49
Milan 48
Salt Lake City 48
Buffalo 43
Lauterbourg 43
Shanghai 41
Dublin 38
Tokyo 37
Columbus 31
Moscow 30
Orem 25
Falls Church 23
Des Moines 22
Jakarta 22
Atlanta 21
Elk Grove Village 21
Dong Ket 20
Toronto 20
São Paulo 19
Tampa 19
New Malden 18
Haiphong 17
Phoenix 17
Tel Aviv 17
Brussels 16
Da Nang 15
Istanbul 15
Ottawa 15
Paris 15
Kuala Lumpur 14
Manchester 14
Nagoya 14
New Delhi 14
Norwalk 14
Palo Alto 14
Rome 14
San Mateo 14
Amsterdam 13
Jambes 13
Johannesburg 13
Mexico City 13
Rio de Janeiro 13
San Francisco 13
Brooklyn 12
Denver 12
Buenos Aires 11
Munich 11
Nanjing 11
Nuremberg 11
Turku 11
Boston 10
Cairo 10
Chennai 10
Dhaka 10
Lancaster 10
Miami 10
Montreal 10
Mumbai 10
Philadelphia 10
Quito 10
Reggio Nell'emilia 10
Belize City 9
Totale 10.226
Nome #
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 938
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 767
T-cell lymphoma in South America and Europe. 510
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 481
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 467
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 404
Follicular lymphoma international prognostic index. 388
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy 374
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 369
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 356
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 335
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 333
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 333
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 322
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 315
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 313
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 305
Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone 300
[The protective effect of cyclosporine A, carnitine, and Mg(2+) with ADP during calcium(2+)-dependent permeabilization of mitochondria by fatty acids and activation of NADH oxidation by an external pathway] 297
T-cell lymphomas: where we are and where we a re moving forward 292
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi Study 292
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials 285
T-cell project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma 277
Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: Results of the central review of 573 cases from the T-Cell Project, an international, cooperative study 275
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results. 275
Watchful waiting in low-tumorburden follicular lymphoma in the Rituximab era. Results of a F2 observational 272
[Damage to calcium ion-loaded mitochondria by fatty acids and the protective effect of carnitine] 262
Effect of cardiolipin on functional properties of isolated rat liver mitochondria 256
Effects of single or multiple doses of L-carnitine on liver energetic metabolism of rats forced to run 246
Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone 240
Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine 238
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: Results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL) 230
Follicular Lymphoma - treatment and prognostic factors. 226
Comparative studies of effects of dehydroepiandrosterone on rat and chicken liver 226
Clinicopathologic characteristics of angioimmunoblastics T-cell lymphoma (AITL): analysis of 243 cases from the International Peripheral T-cell Lymphoma Project. 222
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: A report from the prospective international T-cell project 221
Effects of dehydroepiandrosterone and carnitine treatment on rat liver 216
The protecting effect of L-carnitine on Ca(2+)-loaded rat liver mitochondria 208
Follicular lymphomas: is there a chance for cure? 207
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 207
Prognosis factors in low-grade Non-Hodgkin's lymphomas 206
Interaction of carnitine with mitochondrial cardiolipin 199
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial 199
Sources of intramitochondrial malate 195
BEACOPP or no BEACOPP 191
The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis 190
Induction of thermogenic enzymes by DHEA and its metabolites 187
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials 179
The prognosis of follicular lymphomas: The F2-project 173
Totale 14.799
Categoria #
all - tutte 50.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/20221.097 35 121 139 68 34 56 71 84 108 75 188 118
2022/20231.290 111 135 76 126 162 172 42 162 151 23 73 57
2023/20241.333 40 61 60 72 204 108 127 565 21 15 11 49
2024/20251.989 59 13 12 157 434 293 168 108 246 97 187 215
2025/20264.139 253 129 401 457 649 314 503 178 404 342 296 213
Totale 14.799